FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059334340> ?p ?o ?g. }

• W2059334340 endingPage "24498" @default.
• W2059334340 startingPage "24494" @default.
• W2059334340 abstract "Bik is a potent pro-apoptotic protein, which complexes with various anti-apoptotic proteins such as Bcl-2, Bcl-xL, 19-kDa adenovirus E1B, and EBV-BHRF1. The mechanism by which Bik promotes cell death is not known. It shares a conserved domain, BH3, with other pro-apoptotic proteins, Bax, Bak, Bid, and Hrk, and certain anti-apoptosis proteins such as Bcl-2 and Bcl-xL. Mutations within the BH3 domain of Bik abrogate its ability to induce cell death and to complex with anti-apoptosis proteins. This result is consistent with the hypothesis that Bik may promote cell death by complexing with and antagonizing the activity of endogenous cellular anti-apoptosis proteins such as Bcl-2 and Bcl-xL. To elucidate the relationship between protein complex formation and induction of cell death, we have identified the minimal sequences of Bik, from a library of N-terminal and C-terminal deletion mutants, required for interaction with Bcl-2 and Bcl-xL and for inducing efficient cell death. Two-hybrid analysis in yeast and immunoprecipitation analysis of proteins expressed in mammalian cells indicate that a 52-amino acid region (amino acids 43–94) of Bik, encompassing the BH3 domain, is sufficient for efficient heterodimerization with Bcl-2 and Bcl-xL. Protein interaction studies further reveal that an 18-amino acid region, encompassing the BH3 domain (residues 57–74), constitutes the core heterodimerization domain. Functional analysis indicates that a Bik deletion mutant expressing residues 43–120, which efficiently heterodimerizes with the anti-apoptosis proteins Bcl-2 and Bcl-xL, is defective in eliciting cell death. In contrast, a mutant expressing additional C-terminal sequences (amino acids 43–134) interacts with the survival proteins and elicits efficient cell death. Our results suggest that for Bik-mediated cell death, the heterodimerization activity encoded by the BH3 domain alone is insufficient and raise the possibility that Bik may induce cell death autonomous of heterodimerization with survival proteins such as Bcl-2 and Bcl-xL. Bik is a potent pro-apoptotic protein, which complexes with various anti-apoptotic proteins such as Bcl-2, Bcl-xL, 19-kDa adenovirus E1B, and EBV-BHRF1. The mechanism by which Bik promotes cell death is not known. It shares a conserved domain, BH3, with other pro-apoptotic proteins, Bax, Bak, Bid, and Hrk, and certain anti-apoptosis proteins such as Bcl-2 and Bcl-xL. Mutations within the BH3 domain of Bik abrogate its ability to induce cell death and to complex with anti-apoptosis proteins. This result is consistent with the hypothesis that Bik may promote cell death by complexing with and antagonizing the activity of endogenous cellular anti-apoptosis proteins such as Bcl-2 and Bcl-xL. To elucidate the relationship between protein complex formation and induction of cell death, we have identified the minimal sequences of Bik, from a library of N-terminal and C-terminal deletion mutants, required for interaction with Bcl-2 and Bcl-xL and for inducing efficient cell death. Two-hybrid analysis in yeast and immunoprecipitation analysis of proteins expressed in mammalian cells indicate that a 52-amino acid region (amino acids 43–94) of Bik, encompassing the BH3 domain, is sufficient for efficient heterodimerization with Bcl-2 and Bcl-xL. Protein interaction studies further reveal that an 18-amino acid region, encompassing the BH3 domain (residues 57–74), constitutes the core heterodimerization domain. Functional analysis indicates that a Bik deletion mutant expressing residues 43–120, which efficiently heterodimerizes with the anti-apoptosis proteins Bcl-2 and Bcl-xL, is defective in eliciting cell death. In contrast, a mutant expressing additional C-terminal sequences (amino acids 43–134) interacts with the survival proteins and elicits efficient cell death. Our results suggest that for Bik-mediated cell death, the heterodimerization activity encoded by the BH3 domain alone is insufficient and raise the possibility that Bik may induce cell death autonomous of heterodimerization with survival proteins such as Bcl-2 and Bcl-xL. Apoptosis is a normal physiological process required for selective elimination of cells in multicellular organisms. This process is either positively or negatively modulated by a number of external and internal factors. The bcl-2 proto-oncogene is a well known inhibitor of apoptosis (reviewed in Refs. 1Reed J.C. J. Cell Biol. 1995; 124: 1-6Crossref Scopus (2384) Google Scholar and 2Korsmeyer S.J. Blood. 1992; 80: 879-886Crossref PubMed Google Scholar). Recently, a number of vertebrate cellular and viral proteins structurally related to Bcl-2 have been identified. The various Bcl-2 homologs have been shown to possess either anti-apoptotic or pro-apoptotic activity. The pro-apoptotic homologs include Bax (3Oltvai Z.N. Milliman C.L. Korsmeyer S.J. Cell. 1993; 74: 609-619Abstract Full Text PDF PubMed Scopus (5820) Google Scholar), Bak (4Chittenden T. Harrington E.A. O'Connor R. Flemington C. Lutz R.J. Evan G.I. Guild B.C. Nature. 1995; 374: 733-736Crossref PubMed Scopus (692) Google Scholar, 5Farrow S.N. White J.H. Martinou I. Raven T. Pun K.T. Grinham C.J. Martinou J.C. Brown R. Nature. 1995; 374: 731-733Crossref PubMed Scopus (468) Google Scholar, 6Kiefer M.C. Brauer M.J. Powers V.C. Wu J.J. Umansky S.R. Tomei L.D. Barr P.J. Nature. 1995; 374: 736-739Crossref PubMed Scopus (495) Google Scholar), Bik (7Boyd J.M. Gallo G.J. Elangovan B. Houghton A.B. Malstrom S. Avery B.J. Ebb R.G. Subramanian T. Chittenden T. Lutz R.J. Chinnadurai G. Oncogene. 1995; 11: 1921-1928PubMed Google Scholar, 8Han J. Sabbatini P. White E. Mol. Cell. Biol. 1996; 16: 5857-5864Crossref PubMed Scopus (169) Google Scholar), Bid (9Wang K. Yin X.-M. Chao D.T. Millman C.T. Korsmeyer S.J. Genes Dev. 1996; 10: 2859-2869Crossref PubMed Scopus (801) Google Scholar), and Hrk (10Inohara N. Ding L. Chen D. Nunez G. EMBO J. 1997; 16: 1638-1686Crossref PubMed Scopus (326) Google Scholar), which function as dominant death inducers when overexpressed. The mechanism(s) by which anti-apoptotic and pro-apoptotic proteins elicit their respective activities are not known. A common feature of the various Bcl-2 family members is that they form homo- and heterodimeric complexes (3Oltvai Z.N. Milliman C.L. Korsmeyer S.J. Cell. 1993; 74: 609-619Abstract Full Text PDF PubMed Scopus (5820) Google Scholar, 11Yin X.M. Oltvai Z.N. Korsmeyer S.J. Nature. 1994; 369: 321-323Crossref PubMed Scopus (1212) Google Scholar, 12Sedlak T.W. Oltvai Z.N. Yang E. Wang K. Boise L.H. Thompson C.B. Korsmeyer S.J. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 7834-7838Crossref PubMed Scopus (780) Google Scholar). Based on this observation, it has been proposed that anti-apoptotic proteins such as Bcl-2 promote cell survival by complexing with pro-apoptotic proteins such as Bax, thereby antagonizing the death-promoting activity of these proteins (3Oltvai Z.N. Milliman C.L. Korsmeyer S.J. Cell. 1993; 74: 609-619Abstract Full Text PDF PubMed Scopus (5820) Google Scholar, 11Yin X.M. Oltvai Z.N. Korsmeyer S.J. Nature. 1994; 369: 321-323Crossref PubMed Scopus (1212) Google Scholar). However, it has recently been observed that certain mutants of Bcl-xL, defective in complex formation with Bax and Bak, are still able to promote cell survival (13Cheng E.H. Levine B. Boise L.H. Thompson C.B. Hardwick J.M. Nature. 1996; 379: 554-556Crossref PubMed Scopus (443) Google Scholar). This raises the possibility that at least certain anti-apoptotic members of the Bcl-2 family of proteins may promote cell survival independently of their interaction with known pro-apoptotic proteins such as Bax and Bak. The pro-apoptotic proteins Bax and Bak are closely related to Bcl-2 whereas Bik is more distantly related. Bax and Bak contain three conserved domains, BH1, BH2, and BH3, similar to Bcl-2, in addition to the characteristic C-terminal transmembrane domain common to all Bcl-2 family proteins. In contrast, Bik shares only the BH3 and the C-terminal transmembrane domains with other Bcl-2 family proteins. The presence of the BH3 domain in Bik, which is otherwise unrelated to Bax and Bak, suggests a critical role for the BH3 domain in the common cell death-inducing activity of the three different proteins. The dual role of the BH3 domain in inducing cell death and mediating heterodimerization with survival proteins was elucidated by detailed mutagenesis of Bak, where a minigene encoding a 51-amino acid region, encompassing the BH3 domain, was found to be sufficient for inducing cell death and for heterodimerization with Bcl-xL (14Chittenden T. Flemington C. Houghton A.B. Ebb R.G. Gallo G.J. Elangovan B. Chinnadurai G. Lutz R.J. EMBO J. 1995; 14: 5589-5596Crossref PubMed Scopus (436) Google Scholar). Further, mutations within the BH3 domain of Bak, Bax, and Bik were found to abrogate the ability of these proteins to heterodimerize with the survival proteins such as Bcl-2 and Bcl-xL and to eliminate their apoptotic activity (7Boyd J.M. Gallo G.J. Elangovan B. Houghton A.B. Malstrom S. Avery B.J. Ebb R.G. Subramanian T. Chittenden T. Lutz R.J. Chinnadurai G. Oncogene. 1995; 11: 1921-1928PubMed Google Scholar, 14Chittenden T. Flemington C. Houghton A.B. Ebb R.G. Gallo G.J. Elangovan B. Chinnadurai G. Lutz R.J. EMBO J. 1995; 14: 5589-5596Crossref PubMed Scopus (436) Google Scholar). Like Bik, two recently identified pro-apoptotic proteins, Bid (9Wang K. Yin X.-M. Chao D.T. Millman C.T. Korsmeyer S.J. Genes Dev. 1996; 10: 2859-2869Crossref PubMed Scopus (801) Google Scholar) and Hrk (10Inohara N. Ding L. Chen D. Nunez G. EMBO J. 1997; 16: 1638-1686Crossref PubMed Scopus (326) Google Scholar), that complex with Bcl-2 and Bcl-xL share only the BH3 domain with other Bcl-2 family members. Thus, the two activities (i.e. heterodimerization with survival proteins and induction of cell death) of Bax, Bak, Bik, Bid, and Hrk mediated by the BH3 domain appear to be linked. These results are consistent with the hypothesis that these pro-apoptotic proteins promote cell death by complexing with endogenous survival proteins such as Bcl-2 and Bcl-xL. The results presented in this report suggest that complex formation of Bik with Bcl-2 and Bcl-xL alone is insufficient for promoting cell death. Efficient Bik-mediated cell death requires additional sequence elements, in addition to the conserved BH3 domain. To construct N-terminal deletion mutants of Bik, the plasmid pACT-Bik (7Boyd J.M. Gallo G.J. Elangovan B. Houghton A.B. Malstrom S. Avery B.J. Ebb R.G. Subramanian T. Chittenden T. Lutz R.J. Chinnadurai G. Oncogene. 1995; 11: 1921-1928PubMed Google Scholar) was linearized with BamHI, treated with Bal-31 nuclease (Life Technologies, Inc.) for various lengths of time, and then digested with SalI (3′ end of Bik cDNA). DNA fragments were isolated by agarose electrophoresis and ligated with the vector pACT (between BamHI (blunt ended with T4 DNA polymerase) and SalI sites). The ligated DNA was introduced into Escherichia coli DH5α by electroporation. Transformed colonies (∼103) were pooled by scraping and amplified for purification of library DNA. To construct C-terminal deletion mutants of Bik, pACT-Bik was linearized with SmaI (located near the 3′ end of the Bik open reading frame) and digested with Bal-31 and then with BamHI. DNA fragments were purified and ligated to pACT (between SalI (blunt ended) andBamHI sites) and cloned. Yeast indicator strain GGY1::171 was transformed with the bait plasmid expressing a fusion protein consisting of the human Bcl-2 protein tagged with the GAL4 DNA binding domain (pMA424-Bcl2; Ref. 15Boyd J.M. Malstrom S. Subramanian T. Venkatesh L.K. Schaeper U. Elangovan B. D'Sa-Eipper C. Chinnadurai G. Cell. 1994; 79: 341-351Abstract Full Text PDF PubMed Scopus (391) Google Scholar) and the GAL4 activation domain tagged with the Bik prey plasmid (pACT-Bik) and mutant library using established procedures (16Fields S. Song O.K. Nature. 1989; 340: 245-246Crossref PubMed Scopus (4793) Google Scholar, 17Durfee T. Becherer K. Chen P.L. Yeh S.H. Yang Y. Kilburn A.E. Lee W.H. Elledge S.J. Genes Dev. 1993; 7: 555-569Crossref PubMed Scopus (1295) Google Scholar). DNA of the positivebik mutants were isolated and sequenced by femtomole cycle sequencing. BSC40 or MCF-7 cells were infected with vaccinia virus vTF7–3 (10 plaque-forming units/cell) and cotransfected with 3 μg of each plasmid (pcDNA3-based) expressing Bcl-2 or Bcl-xL (18Boise L.H. Gonzalez-Garcia M. Postema C.E. Ding L. Lindsten T. Turka L.A. Mao X. Nunez G. Thompson C.B. Cell. 1993; 74: 597-608Abstract Full Text PDF PubMed Scopus (2907) Google Scholar) and HA 1The abbreviations used are: HA, hemagglutinin; PAGE, polyacrylamide gel electrophoresis; X-gal, 5-bromo-4-chloro-3-indolyl β-d-galactopyranoside; aa, amino acid(s). epitope-tagged Bik or Bik mutants. The cells were labeled with [35S]methionine mix (150 μCi/ml) in methionine-free medium (20–22 h postinfection) and lysed with TNN buffer (40 mm Tris-Cl, pH 7.5, 150 mm NaCl, 0.5% Nonidet P-40, 2 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 mm phenylmethylsulfonyl fluoride). The HA epitope-tagged proteins were immunoprecipitated and resolved by 15% SDS-PAGE electrophoresis. The expression of Bcl-2 was confirmed by immunoprecipitation with the anti-Bcl-2 antibody, 4D7 (Pharmingen) whereas Bcl-xL expression (tagged with the Flag epitope) was confirmed by immunoprecipitation with the anti-Flag antibody (Kodak). MCF-7 cells were transfected with HA epitope-tagged Bik or Bik mutants (2 μg) expressed from the pcDNA3 vector along with the reporter plasmid pRSV-βgal (0.5 μg). After 9–10 h of transfection, the cells were fixed, stained with X-gal, and microscopically examined. 100–200 blue color cells were microscopically scored as flat (live) and round (apoptotic) cells. To determine the minimal sequences of Bik required for interaction with anti-apoptosis proteins, we used a library of N-terminal deletion mutants of Bik generated by Bal-31 nuclease digestion. The mutants competent for interaction with Bcl-2 were identified by two-hybrid analysis in yeast (13Cheng E.H. Levine B. Boise L.H. Thompson C.B. Hardwick J.M. Nature. 1996; 379: 554-556Crossref PubMed Scopus (443) Google Scholar). Yeast colonies expressing the positively interacting bik mutants were identified on the basis of activation of expression of the lacZ reporter gene. The level of interaction was assessed from the intensity of blue color in the X-gal filter β-galactosidase assay. Ten different yeast colonies that showed intense blue color in the X-gal assay were randomly selected, and the pACT-Bik plasmids were recovered by bacterial transformation. DNA sequence analysis of these mutants revealed four different N-terminal end points starting at codons 29, 34, 38, and 43 (Fig. 1,b–e). The relative levels of interaction of these deletion mutants were more or less similar to that of wt Bik (Fig.1 a). To determine if additional sequences at the N-terminal region could be deleted without abolishing interaction with Bcl-2, a different bik mutant library was prepared after more extensive digestion with Bal-31 nuclease and analyzed by two-hybrid assay. Most of the yeast colonies resulting from transformation of this library and the Bcl-2 bait were white in the X-gal assay indicating lack of interaction. However, two weakly interacting clones (which showed less intense blue color in the X-gal assay) were identified. DNA sequence analysis of these bik clones revealed that both clones had a single N-terminal end at codon 57 (Fig. 1 f). These results indicate that residue 57 defines the N terminus of the minimal Bik protein required for heterodimerization with Bcl-2 whereas additional residues up to 43 amino acids are required for more efficient interaction. To determine the C-terminal boundary, a similar Bal-31 nuclease-mediated deletion mutagenesis of pACT-Bik (wt) was performed, and the products were analyzed for interaction by two-hybrid analysis. Among the positively interacting clones, 18 were sequenced and 4 were chosen for further analysis. These clones had C-terminal ends at residues 96, 82, 78, and 74 (Fig. 1, g–j). Among the four mutants, mutant j (Fig. 1 j) was interesting since it had the largest deletion and interacted with Bcl-2 better than mutant i. However, mutant j contained an additional 21 missense amino acids (unrelated to Bik, resulting from mutagenesis and cloning) at the C terminus compared with mutant i, which had only four missense amino acids. To determine if a truncation mutant of Bik with an additional deletion of the C-terminal sequences can interact with Bcl-2, a different mutant of pACT-Bik expressing the N-terminal 72 amino acids was constructed by site-directed mutagenesis and analyzed for heterodimerization (Fig. 1 k). This truncation mutant was defective in interaction with Bcl-2, suggesting that an additional C-terminal sequence is required for BH3-mediated interaction with Bcl-2. These results indicate that Bik residues 57–74 may constitute the core heterodimerization motif and that additional flanking sequences are required to facilitate heterodimerization with Bcl-2. To identify the minimal domain of Bik that interacts with Bcl-2 efficiently, we introduced three different C-terminal truncation mutations by polymerase chain reaction in the N-terminal deletion mutant 43–160. Interaction of the three mutants with Bcl-2 was determined by two-hybrid analysis. These two-hybrid analyses indicated that two of these mutants, 43–134 (Fig. 1 l) and 43–120 (Fig. 1 m), interacted with Bcl-2 as strongly as the parental 43–160 mutant whereas the third mutant 43–94 (Fig. 1 n) interacted at a reduced level. As expected, a deletion mutation (ΔGD) within the BH3 domain of Bik mutants 43–94 (Fig. 1 o) and 43–120 (Fig. 1 p) abolished their interaction with Bcl-2 underscoring the requirement of the BH3 domain for heterodimerization. The ability of the three deletion mutants, 43–94, 43–120, and 43–134, to heterodimerize with cellular anti-apoptosis proteins Bcl-2 and BclxL was investigated by coimmunoprecipitation analysis in mammalian cells. For this purpose, the wt Bik and mutants were tagged with the HA epitope and coexpressed with Bcl-2 or Bcl-xL in BSC40 cells using the vaccinia virus expression system (19Fuerst T.R. Niles E.G. Studier F.W. Moss B. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 8122-8126Crossref PubMed Scopus (1860) Google Scholar). The proteins were immunoprecipitated with the HA antibody or the antibody specific for the survival proteins. In these studies, Bik mutants with deletions in the BH3 domain (ΔGD) were used as the negative control. As shown in Fig.2 A, Bcl-2 is coimmunoprecipitated with full-length HA-Bik as well as with the Bik deletion mutants HA-Bik(43–134) and HA-Bik(43–120) when the protein extracts were immunoprecipitated with the HA monoclonal antibody. Although the expression of the mutant HA-Bik-(43–94) was generally poor (compared with other mutants), it was also found to complex with Bcl-2 at detectable levels. It should be noted that expression of the various Bik mutants in the absence of Bcl-2 was generally lower than in cells expressing Bcl-2. It is possible the protein heterodimerization may stabilize the mutant proteins. As expected, there was no significant coprecipitation of Bcl-2 with the HA-BikΔGD (BH3) mutant, suggesting that the interaction is specific. Similarly, HA antibody did not precipitate Bcl-2 from cells that were not transfected with Bik expression vectors. These results indicate that all three deletion mutants of Bik can form a complex with Bcl-2 in mammalian cells and are in good agreement with the two-hybrid data. Similar coimmunoprecipitation studies were also carried out with extracts from cells transfected with Bcl-xL (tagged with Flag epitope) and Bik (Fig. 2 B). In general, the relative level of interaction between Bik and Bcl-xL was stronger. Coexpression of HA-Bik wt or the various HA-Bik mutants with Bcl-xL resulted in highly efficient coprecipitation, and in contrast, coexpression with the BikΔGD mutant did not result in detectable amounts of Bcl-xL coprecipitation. Interestingly, coexpression of the Bik mutants with Bcl-xLresulted in high levels of Bik expression. These results indicate that all three deletion mutants of Bik efficiently heterodimerize with Bcl-xL. To determine if the two activities of Bik (i.e. ability to heterodimerize with survival proteins and to induce cell death) can be separated, we then determined the apoptotic activities of the threebik mutants by transient DNA transfection (14Chittenden T. Flemington C. Houghton A.B. Ebb R.G. Gallo G.J. Elangovan B. Chinnadurai G. Lutz R.J. EMBO J. 1995; 14: 5589-5596Crossref PubMed Scopus (436) Google Scholar, 20Miura M. Zhu H. Rotello R. Hartwieg E.A. Yuan J. Cell. 1993; 75: 653-660Abstract Full Text PDF PubMed Scopus (1323) Google Scholar) in MCF-7 cells. Expression of wt Bik resulted in about 80% apoptotic cells among the transfected cells (Fig.3 A). Similarly, expression of the mutant 43–134 induced cell death at levels comparable with that ofwt Bik. In contrast, cells transfected with the corresponding mutant constructs containing the BH3 deletion (ΔGD) mutation did not exhibit significantly higher frequency of cell death compared with cells transfected with the pcDNA3-HA vector. Interestingly, the heterodimerization-positive mutants 43–120 and 43–94 (as well as their derivatives containing the ΔGD mutation) were defective in induction of cell death. To resolve if the defect in induction of cell death by mutants 43–120 and 43–94 is not due to lack of mutant Bik protein expression in MCF-7 cells, we examined the expression of mutant proteins by immunoprecipitation analysis (Fig. 3 B). Although mutant 43–94 was expressed at relatively low levels, mutant 43–120 was expressed at significant levels. Since cells transfected with the mutant 43–120 do not exhibit any higher cell death compared with cells transfected with the pcDNA3-HA vector, it appears that additional sequences encompassing residues 121–134 are essential for efficient Bik-mediated cell death. The requirement of amino acids (aa) 121–134 for Bik-induced cell death was also confirmed using a different Bik mutant (Δ121–134) containing an internal deletion of residues 121–134 within Bik43–160 (Figs. 4 B and5). A data bank search revealed that this region is significantly homologous to the substrate binding pocket (position P4) domain of Ced-3/ICE family caspases (22Walker N.P.C. Talanian R.V. Brady K.D. Dang L.C. Bump N.J. Ferenz C.R. Franklin S. Ghayur T. Hackett M.C. Hammill L.D. Herog L. Hugunin M. Houy W. Mankovich J.A. McGuiness L. Orlewicz E. Paskind M. Pratt C.A. Reis P. Summani A. Terranova M. Welch J.P. Xiong L. Moller A. Tracey D.E. Kamen R. Wong W.W. Cell. 1994; 78: 343-352Abstract Full Text PDF PubMed Scopus (524) Google Scholar, 23Wilson K.P. Black J.A. Thomson J.A. Kim E.E. Griffith J.P. Navia M.A. Murcko M.A. Chambers S.P. Aldape R.A. Raybuck S.A. Livingston D.J. Nature. 1994; 370: 270-275Crossref PubMed Scopus (751) Google Scholar) that mediate apoptosis (Fig. 4 A). To determine the role of this motif in Bik-induced cell, we introduced a deletion mutation (ΔWW; residues 122–130) within the death-inducing Bik truncation mutant 43–134. Similarly, a different two-amino acid substitution mutant (R123A/S129A) was also constructed (Fig. 4 B). The cell death activity of these mutants was determined by transient transfection. Deletion of the entire pocket motif impaired the death activity of Bik(43–134) by about one-half, and mutation of the conserved Arg123 and Ser129 residues (R123A/S129A) resulted in modest reduction in the cell death activity compared with Bik-(43–134). These results suggest that the sequences encompassing residues 121–134 are required for efficient Bik-mediated cell death, and the sequence motif similar to the substrate binding pocket of Ced-3/ICE caspases may constitute part of these sequences.Figure 5Induction of apoptosis by Bik C-terminal mutants. A, cell death activity of Bik mutants.B, immunoprecipitation analysis of Bik C-terminal mutants. The apoptosis assays were carried out and quantitated as described in the legend to Fig. 3. 35S-Labeled proteins were immunoprecipitated from extracts of MCF-7 cells transfected with various HA-tagged Bik plasmids, immunoprecipitated with HA antibody, and analyzed by 15% SDS-PAGE and autoradiography.View Large Image Figure ViewerDownload Hi-res image Download (PPT) We have utilized the yeast two-hybrid assay to identify minimal Bik sequences required for interaction with Bcl-2 from libraries ofbik mutants. These studies indicate that a 52-amino acid region encompassing the BH3 domain of Bik is sufficient for heterodimerization with Bcl-2 and Bcl-xL. This result is in good agreement with the results obtained with two other cell death-inducing proteins Bak (14Chittenden T. Flemington C. Houghton A.B. Ebb R.G. Gallo G.J. Elangovan B. Chinnadurai G. Lutz R.J. EMBO J. 1995; 14: 5589-5596Crossref PubMed Scopus (436) Google Scholar) and Bax (21Zha H. Aime-Sempe C. Sato T. Reed J.C. J. Biol. Chem. 1996; 271: 7440-7444Abstract Full Text Full Text PDF PubMed Scopus (411) Google Scholar). In the case of Bak, a 51-amino acid region (aa 73–123), and in the case of Bax, a 43-amino acid region (aa 59–101), both proteins encompassing the BH3 domain have been shown to be sufficient for heterodimerization with Bcl-xL and Bcl-2, respectively. Since our two-hybrid analysis indicates that a 18-amino acid region located between residues 57 and 74 mediates heterodimerization, the adjoining sequences may play a facilitating role. Recent in vitro peptide binding studies indicate that 16-amino acid regions encompassing the BH3 domains of Bak, Bax, and Bik can bind with Bcl-xL (24Sattler M. Liang H. Nettesheim D. Meadows R.P. Harlan J.E. Eberstadt M. Yoon H.S. Shuker S.B. Chang B.S. Minn A.J. Thompson C.B. Fesik S.W. Science. 1997; 275: 983-986Crossref PubMed Scopus (1277) Google Scholar). The results of these in vitro studies are in good agreement with the data from our two-hybrid analysis. An important outcome of our present studies is the identification of mutants of Bik (e.g. Bik-(43–94) and Bik-(43–120)) that heterodimerize with cellular anti-apoptosis proteins Bcl-2 and Bcl-xL and are unable to induce efficient cell death. Previous studies have indicated that the cell death activities of Bak, Bax, and Bik are closely linked with their ability to heterodimerize with survival proteins (7Boyd J.M. Gallo G.J. Elangovan B. Houghton A.B. Malstrom S. Avery B.J. Ebb R.G. Subramanian T. Chittenden T. Lutz R.J. Chinnadurai G. Oncogene. 1995; 11: 1921-1928PubMed Google Scholar, 14Chittenden T. Flemington C. Houghton A.B. Ebb R.G. Gallo G.J. Elangovan B. Chinnadurai G. Lutz R.J. EMBO J. 1995; 14: 5589-5596Crossref PubMed Scopus (436) Google Scholar). Similarly, mutations within the BH3 domain of two recently identified pro-apoptotic proteins Bid (9Wang K. Yin X.-M. Chao D.T. Millman C.T. Korsmeyer S.J. Genes Dev. 1996; 10: 2859-2869Crossref PubMed Scopus (801) Google Scholar) and Hrk (10Inohara N. Ding L. Chen D. Nunez G. EMBO J. 1997; 16: 1638-1686Crossref PubMed Scopus (326) Google Scholar) impair their ability to heterodimerize with survival proteins and to induce cell death. These results are consistent with a model that the five different pro-apoptotic proteins may mediate cell death by complexing with endogenous survival proteins such as Bcl-2 and Bcl-xL. Our present results indicate that interaction of Bik with anti-apoptosis proteins alone is insufficient for induction of cell death by Bik. Although we cannot rule out that the death-promoting activity of Bik is dependent on its interaction with cellular anti-apoptosis proteins, our results would be consistent with a model that Bik promotes cell death independently of such interaction. Our present results also indicate that sequences of Bik encompassing a C-terminal region (aa 120–134) are required (in addition to the BH3 domain) for efficient cell death activity in MCF-7 cells. These sequences are not conserved in other pro-apoptotic members such as Bax, Bak, Bid, and Hrk. Since the BH3 domain plays a central role in mediating cell death by the various pro-apoptotic members, it is possible that in Bik, the C-terminal sequences may function in concert with the BH3 domain whereas in other pro-apoptotic proteins, the BH3 domain may function more autonomously or in concert with other yet unknown auxiliary sequence elements. The precise biochemical activity of the C-terminal region of Bik is not known. Although this region contains a sequence motif similar to the substrate binding motif of Ced-3/ICE family caspases, it remains to be determined if this motif modulates the substrate-caspase complexes. Simpler explanations such as the C-terminal region playing a role in Bik protein folding are also possible. We thank V. M. Dixit and A. M. Chinnaiyan for MCF-7 cells." @default.
• W2059334340 created "2016-06-24" @default.
• W2059334340 creator A5048090668 @default.
• W2059334340 creator A5075440016 @default.
• W2059334340 date "1997-09-01" @default.
• W2059334340 modified "2023-09-30" @default.
• W2059334340 title "Functional Dissection of the Pro-apoptotic Protein Bik" @default.
• W2059334340 cites W103053889 @default.
• W2059334340 cites W1628370182 @default.
• W2059334340 cites W1816247929 @default.
• W2059334340 cites W1977186059 @default.
• W2059334340 cites W1994068418 @default.
• W2059334340 cites W2003301112 @default.
• W2059334340 cites W2005411001 @default.
• W2059334340 cites W2019572526 @default.
• W2059334340 cites W2033847504 @default.
• W2059334340 cites W2057315090 @default.
• W2059334340 cites W2058591356 @default.
• W2059334340 cites W2063176993 @default.
• W2059334340 cites W2064967819 @default.
• W2059334340 cites W2077270970 @default.
• W2059334340 cites W2087092800 @default.
• W2059334340 cites W2088187860 @default.
• W2059334340 cites W2105253445 @default.
• W2059334340 cites W2106799894 @default.
• W2059334340 cites W2107237397 @default.
• W2059334340 cites W2134979684 @default.
• W2059334340 cites W2139360111 @default.
• W2059334340 cites W2142946131 @default.
• W2059334340 cites W4233484287 @default.
• W2059334340 doi "https://doi.org/10.1074/jbc.272.39.24494" @default.
• W2059334340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9305912" @default.
• W2059334340 hasPublicationYear "1997" @default.
• W2059334340 type Work @default.
• W2059334340 sameAs 2059334340 @default.
• W2059334340 citedByCount "61" @default.
• W2059334340 countsByYear W20593343402012 @default.
• W2059334340 countsByYear W20593343402013 @default.
• W2059334340 countsByYear W20593343402014 @default.
• W2059334340 countsByYear W20593343402015 @default.
• W2059334340 countsByYear W20593343402016 @default.
• W2059334340 countsByYear W20593343402017 @default.
• W2059334340 countsByYear W20593343402020 @default.
• W2059334340 countsByYear W20593343402021 @default.
• W2059334340 crossrefType "journal-article" @default.
• W2059334340 hasAuthorship W2059334340A5048090668 @default.
• W2059334340 hasAuthorship W2059334340A5075440016 @default.
• W2059334340 hasConcept C105702510 @default.
• W2059334340 hasConcept C185592680 @default.
• W2059334340 hasConcept C190283241 @default.
• W2059334340 hasConcept C2775862295 @default.
• W2059334340 hasConcept C55493867 @default.
• W2059334340 hasConcept C86803240 @default.
• W2059334340 hasConcept C95444343 @default.
• W2059334340 hasConceptScore W2059334340C105702510 @default.
• W2059334340 hasConceptScore W2059334340C185592680 @default.
• W2059334340 hasConceptScore W2059334340C190283241 @default.
• W2059334340 hasConceptScore W2059334340C2775862295 @default.
• W2059334340 hasConceptScore W2059334340C55493867 @default.
• W2059334340 hasConceptScore W2059334340C86803240 @default.
• W2059334340 hasConceptScore W2059334340C95444343 @default.
• W2059334340 hasIssue "39" @default.
• W2059334340 hasLocation W20593343401 @default.
• W2059334340 hasOpenAccess W2059334340 @default.
• W2059334340 hasPrimaryLocation W20593343401 @default.
• W2059334340 hasRelatedWork W1987695408 @default.
• W2059334340 hasRelatedWork W2147266699 @default.
• W2059334340 hasRelatedWork W2348771880 @default.
• W2059334340 hasRelatedWork W2352094157 @default.
• W2059334340 hasRelatedWork W2614940772 @default.
• W2059334340 hasRelatedWork W2805121851 @default.
• W2059334340 hasRelatedWork W2931523797 @default.
• W2059334340 hasRelatedWork W3046665064 @default.
• W2059334340 hasRelatedWork W3196582013 @default.
• W2059334340 hasRelatedWork W4220681557 @default.
• W2059334340 hasVolume "272" @default.
• W2059334340 isParatext "false" @default.
• W2059334340 isRetracted "false" @default.
• W2059334340 magId "2059334340" @default.
• W2059334340 workType "article" @default.